PRICE T ROWE ASSOCIATES INC /MD/ - ASSERTIO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$1,492,000
-64.5%
1,165,943
-4.2%
0.00%
-100.0%
Q2 2019$4,200,000
-32.0%
1,217,515
+0.0%
0.00%0.0%
Q1 2019$6,172,000
+40.5%
1,217,301
+0.0%
0.00%0.0%
Q4 2018$4,394,000
-39.0%
1,217,101
-0.7%
0.00%0.0%
Q3 2018$7,209,0001,225,9650.00%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 120,600$416,0000.29%
Matarin Capital Management, LLC 762,489$2,631,0000.19%
DELTEC ASSET MANAGEMENT LLC 204,513$706,0000.16%
GLOBEFLEX CAPITAL L P 213,991$738,0000.15%
TSP Capital Management Group, LLC 88,750$306,0000.14%
Spark Investment Management LLC 512,500$1,768,0000.12%
OXFORD ASSET MANAGEMENT LLP 1,141,332$3,938,0000.08%
ALGERT GLOBAL LLC 66,842$231,0000.08%
CIGNA INVESTMENTS INC /NEW 188,018$645,0000.07%
Connor, Clark & Lunn Investment Management Ltd. 3,103,949$10,709,0000.07%
View complete list of ASSERTIO THERAPEUTICS INC shareholders